Literature DB >> 17202798

Effects of propofol and midazolam on lipids, glucose, and plasma osmolality during and in the early postoperative period following coronary artery bypass graft surgery: a randomized trial.

Ilhan Oztekin1, Sümeyye Gökdoğan, Deniz S Oztekin, Halim Işsever, Onur Göksel, Sevim Canik.   

Abstract

It is not clear how levels of serum lipids and glucose and plasma osmolality change during propofol infusion in the pre- and postoperative period of coronary artery bypass graft surgery (CABG). This prospective, randomized, controlled trial evaluated changes in these parameters during propofol or midazolam infusion during and in the early postoperative period following surgery. Twenty patients undergoing CABG were randomized preoperatively into two groups: 10 patients received propofol (induction 1.5 mg/kg, maintenance 1.5 mg kg(-1) h(-1)) and 10 patients received midazolam (induction 0.5 mg/kg, maintenance 0.1 mg kg(-1) h(-1)). Both groups also received fentanyl (induction 20 mug/kg, maintenance 10 microg kg(-1)). Serum lipids, glucose, and plasma osmolality were measured preinduction, precardiopulmonary bypass, at the end of cardiopulmonary bypass, at the end of surgery, and 4 and 24 h postoperatively. In the propofol group, we observed a significant increase in triglycerides and very low-density lipoprotein levels 4 h postoperatively. In the midazolam group, we observed a significant decrease in low-density lipoprotein, cholesterol at the end of cardiopulmonary bypass, end of surgery, and 4 and 24 h postoperatively and significant increase in osmolality at the end of cardiovascular bypass. Changes in glucose levels did not differ significantly different between the two groups. In patients with normal serum lipids, glucose, and plasma osmolality undergoing CABG, propofol infusion for maintenance anesthesia is not associated with dangerous changes in serum lipids, glucose, and plasma osmolality compared with midazolam. A propofol infusion technique for maintenance of anesthesia for cardiac surgery where serum lipids and glucose may be of concern could be recommended as an alternative to midazolam.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17202798     DOI: 10.1248/yakushi.127.173

Source DB:  PubMed          Journal:  Yakugaku Zasshi        ISSN: 0031-6903            Impact factor:   0.302


  4 in total

1.  Six hours positive pressure ventilation with size 5 laryngeal mask in a 55-kg patient.

Authors:  Jayashree Patki; C Naresh K Reddy
Journal:  Indian J Anaesth       Date:  2010-03

2.  The use of mannitol in cardiopulmonary bypass prime solution-Prospective randomized double-blind clinical trial.

Authors:  Magnus Ljunggren; Andreas Sköld; Alain Dardashti; Snejana Hyllén
Journal:  Acta Anaesthesiol Scand       Date:  2019-07-29       Impact factor: 2.105

3.  Effect of Perioperative Lipid Status on Clinical Outcomes after Cardiac Surgery.

Authors:  Maks Mihalj; Paul Philipp Heinisch; Markus Huber; Joerg C Schefold; Alexander Hartmann; Michael Walter; Elisabeth Steinhagen-Thiessen; Juerg Schmidli; Frank Stüber; Lorenz Räber; Markus M Luedi
Journal:  Cells       Date:  2021-10-11       Impact factor: 6.600

4.  Comparison of the changes in blood glucose level during sedation with midazolam and propofol in implant surgery: a prospective randomized clinical trial.

Authors:  Nasser Kaviani; Farzad Koosha; Mina Shahtusi
Journal:  J Dent (Shiraz)       Date:  2014-09
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.